Friday, 5 June 2026
  
Login

Australia's most trusted
source of pharma news

Friday, 05 June 2026
News

Who's flexing the hottest pipeline?

Posted 5 June 2026 AM

Eli Lilly has claimed the number one position on IDEA Pharma’s 2026 Pharmaceutical Invention Index relegating AstraZeneca to second spot.

Released for the first time in 2019 and now in its eighth year, the Invention Index examines pipeline invention and novelty by taking a focused look at the breadth and depth of novel agents currently being developed within the top 30 pharma pipelines.

To see the whole article, please login

Popular

Key leadership changes hit industry
Industry pain point finally solved?
'One-in-a-million' exec departs
Great workplace? GM says no surprise
Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (1)

Sales & Customer Relations (22)

Access & Reimbursement (1)

Clinical & Medical, R&D (8)

Regulatory, Pharmacovigilance & QA (4)

Other (12)

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.


Subscribe
 
© 2003 - 2026 Lush Media | Privacy Statement | Subscribe to Pharma in Focus
home